Your browser doesn't support javascript.
loading
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
O'Donnell, P V; Jones, R J; Vogelsang, G B; Seber, A; Ambinder, R F; Flinn, I; Miller, C; Marcellus, D C; Griffin, C; Abrams, R; Braine, H G; Grever, M; Hess, A D; Piantadosi, S; Noga, S J.
Affiliation
  • O'Donnell PV; The Johns Hopkins Oncology Center, Baltimore, MD 21287, USA.
Bone Marrow Transplant ; 22(10): 947-55, 1998 Nov.
Article in En | MEDLINE | ID: mdl-9849691
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Hematopoietic Stem Cell Transplantation / Antigens, CD34 / Hematologic Neoplasms / Graft vs Host Disease Type of study: Clinical_trials / Etiology_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 1998 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Hematopoietic Stem Cell Transplantation / Antigens, CD34 / Hematologic Neoplasms / Graft vs Host Disease Type of study: Clinical_trials / Etiology_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 1998 Document type: Article Affiliation country: Country of publication: